Suppr超能文献

重组幽门螺杆菌保护性抗原的研究

A study of recombinant protective H.pylori antigens.

作者信息

Jiang Zheng, Tao Xiao-Hong, Huang Ai-Long, Wang Pi-Long

机构信息

Department of Gastroenterology, the First Affiliated Hospital, Chongqing University of Medical Sciences, Chongqing 400016, China.

出版信息

World J Gastroenterol. 2002 Apr;8(2):308-11. doi: 10.3748/wjg.v8.i2.308.

Abstract

AIM

To construct a recombinant vector which can express M (r)26000 outer membrane protein (OMP) from Helicobacter pylori (Hp), and to obtain the vaccine protecting against Hp infection and a diagnostic reagent kit quickly detecting Hp infection.

METHODS

The gene encoding the structural M(r)26000 outer membrane protein of Hp was amplified from Hp chromosomal DNA by PCR, and inserted in the prokaryotic expression vector pET32a (+), which was transformed into the Top10 E. coli strain. Recombinant vector was selected, identified and transformed into BL-21(DE3) E. coli strain. The recombinant fusion proteins were expressed. The antigenicity of recombinant protein was studied by ELISA or immunoblotting and immunized Balb/c mice.

RESULTS

The gene of M(r)26000 OMP was amplified to be 594 base pairs, 1.1% of the cloned genes was mutated and 1.51% of amino acid residues was changed, but there was homogeneity between them. The recombinant fusion protein encoded objective polypeptides of 198 amino acid residues, corresponding to calculated molecular masses of M (r)26000. The level of soluble expression products was about 38.96% of the total cell protein. After purification by Ni-NTA agarose resin columniation, the purity of objective protein became about 90%. The ELISA results showed that recombinant fusion protein could be recognized by patient serum infected with Hp and rabbit serum immunized with the recombinant protein. Furthermore,Balb/c mice immunized with the recombinant protein were protected against H.pylori infection.

CONCLUSION

M (r)26000 OMP may be a candidate vaccine preventing Hp infection.

摘要

目的

构建能表达幽门螺杆菌(Hp)26000分子量外膜蛋白(OMP)的重组载体,快速获得预防Hp感染的疫苗及检测Hp感染的诊断试剂盒。

方法

用聚合酶链反应(PCR)从Hp染色体DNA中扩增编码26000分子量结构外膜蛋白的基因,插入原核表达载体pET32a(+),转化至Top10大肠杆菌菌株。筛选、鉴定重组载体并转化至BL-21(DE3)大肠杆菌菌株。表达重组融合蛋白。通过酶联免疫吸附测定(ELISA)或免疫印迹法研究重组蛋白的抗原性,并免疫Balb/c小鼠。

结果

扩增出的26000分子量OMP基因有594个碱基对,克隆基因的1.1%发生突变,氨基酸残基的1.51%发生改变,但它们之间具有同源性。重组融合蛋白编码198个氨基酸残基的目标多肽,对应计算分子量为26000。可溶性表达产物水平约占总细胞蛋白的38.96%。经镍-亚氨基二乙酸(Ni-NTA)琼脂糖树脂柱纯化后,目标蛋白纯度约为90%。ELISA结果显示,重组融合蛋白能被感染Hp的患者血清及用该重组蛋白免疫的兔血清识别。此外,用重组蛋白免疫的Balb/c小鼠对幽门螺杆菌感染有抵抗力。

结论

26000分子量OMP可能是预防Hp感染的候选疫苗。

相似文献

1
A study of recombinant protective H.pylori antigens.重组幽门螺杆菌保护性抗原的研究
World J Gastroenterol. 2002 Apr;8(2):308-11. doi: 10.3748/wjg.v8.i2.308.

引用本文的文献

6
Recombinant Helicobacter pylori catalase.重组幽门螺杆菌过氧化氢酶
World J Gastroenterol. 2003 May;9(5):1119-22. doi: 10.3748/wjg.v9.i5.1119.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验